ValiRx plc
VAL.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £1,021 | £5,993 | £10,822 | £23,564 |
| - Cash | £1,556 | £175 | £1,137 | £594 |
| + Debt | £12 | £22 | £38 | £59 |
| Enterprise Value | -£523 | £5,840 | £9,723 | £23,029 |
| Revenue | £50 | £10 | £0 | £0 |
| % Growth | 418.5% | – | – | – |
| Gross Profit | -£217 | -£246 | -£224 | -£229 |
| % Margin | -436.4% | -2,562.9% | – | – |
| EBITDA | -£1,862 | -£2,044 | -£2,369 | -£1,449 |
| % Margin | -3,741.2% | -21,295.2% | – | – |
| Net Income | -£1,916 | -£2,038 | -£2,406 | -£1,547 |
| % Margin | -3,848.7% | -21,226.1% | – | – |
| EPS Diluted | -0.015 | -0.02 | -0.031 | -0.024 |
| % Growth | 27.9% | 35.4% | -30.7% | – |
| Operating Cash Flow | -£1,585 | -£1,772 | -£1,712 | -£1,261 |
| Capital Expenditures | -£38 | -£306 | £0 | £0 |
| Free Cash Flow | -£1,623 | -£2,079 | -£1,712 | -£1,261 |